Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam R. Craig currently holds 376,087 shares of CTI BIOPHARMA CORP (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam R. Craig has been a net seller of CTIC stock. They have purchased $282.8K and sold $5.1M worth of shares.
Adam R. Craig's most recent insider trade was on Oct 23, 2025, when they purchased 86,206 shares at $2.90 per share.
Adam R. Craig serves as Executive at CTI BIOPHARMA CORP (CTIC). They have executed 56 insider transactions totaling $5.4M over their tenure at the company.
Adam R. Craig holds the position of Executive at CTI BIOPHARMA CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Adam R. Craig has shown a selling trading pattern, with $282.8K in total purchases and $5.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam R. Craig was on Sep 12, 2022, when they sold $1.6M worth of CTIC shares. This transaction involved 242,300 shares at $6.43 per share.
Adam R. Craig currently owns 376,087 shares of CTI BIOPHARMA CORP (CTIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam R. Craig's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam R. Craig has 56 Form 4 filings on record as an insider at CTI BIOPHARMA CORP.
Set alerts for Adam R. Craig and 40,000+ other insiders.